Charles McNerney
Director/Board Member presso HAPBEE TECHNOLOGIES, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Charles E.
McNerney is an Independent Director at EMulate Therapeutics, Inc. and Hapbee Technologies, Inc. He was the Chief Information Security Officer at Microsoft Corp.
from 1993 to 2019 and the Chief Information Security Officer & VP at Expedia Group, Inc. from 2019 to 2022.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/10/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Charles McNerney
| Società | Posizione | Inizio |
|---|---|---|
| HAPBEE TECHNOLOGIES, INC. | Director/Board Member | 22/05/2019 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Director/Board Member | 01/01/2016 |
Precedenti posizioni note di Charles McNerney
| Società | Posizione | Fine |
|---|---|---|
| EXPEDIA GROUP, INC. | Corporate Officer/Principal | 01/03/2022 |
| MICROSOFT CORPORATION | Corporate Officer/Principal | 01/11/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MICROSOFT CORPORATION | Technology Services |
| EXPEDIA GROUP, INC. | Consumer Services |
| HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
| Aziende private | 1 |
|---|---|
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
- Borsa valori
- Insiders
- Charles McNerney
